Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice

American Journal of Pathology

Volumn 174, Issue 5, 2009, Pages 1766-1775

  Mitchell, Claudia ^a,b   Couton, Dominique ^a,b   Couty, Jean Pierre ^a,b,d   Anson, Marie ^a,b,d   Crain, Anne Marie ^a,b,d   Bizet, Vinciane ^a,b   Rénia, Laurent ^a,b,e   Pol, Stanislas ^a,b,c   Mallet, Vincent ^a,b,c   Gilgenkrantz, Hélène ^a,b,c,f  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c Hôpital Cochin ^*  (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e AGENCY FOR SCIENCE   (Singapore)

^f NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR2; COLLAGENASE 3; GELATINASE A; GLYCOPROTEIN P 15095; TISSUE INHIBITOR OF METALLOPROTEINASE 1; CARBON TETRACHLORIDE; CCR2 PROTEIN, MOUSE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INFLAMMATION; LIVER FIBROSIS; LIVER INJURY; LYMPHOCYTE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; GENETICS; INJURY; LIVER; LIVER CIRRHOSIS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD11C; BLOTTING, WESTERN; CARBON TETRACHLORIDE; FLOW CYTOMETRY; IMMUNOENZYME TECHNIQUES; LIVER; LIVER CIRRHOSIS; MACROPHAGES; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, CCR2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 65649094468     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080632     Document Type: Article

References (36)

1. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005, 115:209-218 (Pubitemid 40385459)
2. Iredale JP: Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007, 117:539-548 (Pubitemid 46348508)
3. Mallet V, Gilgenkrantz H, Serpaggi J, Verkarre V, Vallet-Pichard A, Fontaine H, Pol S: Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C. Ann Intern Med 2008, 149:399-403
4. Rivera CA, Bradford BU, Hunt KJ, Adachi Y, Schrum LW, Koop DR, Burchardt ER, Rippe RA, Thurman RG: Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine. Am J Physiol 2001, 281:G200-G207
5. Novobrantseva TI, Majeau GR, Amatucci A, Kogan S, Brenner I, Casola S, Shlomchik MJ, Koteliansky V, Hochman PS, Ibraghimov A: Attenuated liver fibrosis in the absence of B cells. J Clin Invest 2005, 115:3072-3082 (Pubitemid 41567572)
6. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP: Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005, 115:56-65 (Pubitemid 40385505)
7. Bièche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedossa P, Valla DC, Marcellin P, Vidaud M: Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005, 332:130-144 (Pubitemid 40127235)
8. Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, Pinzani M, Romanelli RG, Laffi G, Gentilini P: Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol 1998, 152:423-430 (Pubitemid 28106388)
9. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N: Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 1997, 94:12053-12058 (Pubitemid 27467841)
10. Couty JP, Crain AM, Gerbaud S, Labasque M, Marchiol C, Fradelizi D, Boudaly S, Guettier C, Vignuzzi M, van der Werf S, Escriou N, Viguier M: Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine. Cancer Immunol Immunother 2008, 57:1161-1171
11. Hokeness KL, Kuziel WA, Biron CA, Salazar-Mather TP: Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J Immunol 2005, 174:1549-1556
12. Moreno C, Gustot T, Nicaise C, Quertinmont E, Nagy N, Parmentier M, Le Moine O, Deviere J, Louis H: CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice. Hepatology 2005, 42:854-862 (Pubitemid 41401123)
13. Murai M, Yoneyama H, Harada A, Yi Z, Vestergaard C, Guo B, Suzuki K, Asakura H, Matsushima K: Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest 1999, 104:49-57 (Pubitemid 29534344)
14. Sakai N, Wada T, Furuichi K, Shimizu K, Kokubo S, Hara A, Yamahana J, Okumura T, Matsushima K, Yokoyama H, Kaneko S: MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J Leukoc Biol 2006, 79:555-563
15. Serbina NV, Pamer EG: Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006, 7:311-317
16. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF: Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007, 117:902-909 (Pubitemid 46556746)
17. Ito A, Suganami T, Yamauchi A, Degawa-Yamauchi M, Tanaka M, Kouyama R, Kobayashi Y, Nitta N, Yasuda K, Hirata Y, Kuziel WA, Takeya M, Kanegasaki S, Kamei Y, Ogawa Y: Role of C-C chemokine receptor 2 in bone marrow cells in the recruitment of macrophages into obese adipose tissue. J Biol Chem 2008, 283:35715-35723
18. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, Iredale JP: Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007, 178:5288-5295 (Pubitemid 46595314)
19. Kurihara T, Warr G, Loy J, Bravo R: Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997, 186:1757-1762 (Pubitemid 27506288)
20. Asselah T, Bieche I, Laurendeau I, Paradis V, Vidaud D, Degott C, Martinot M, Bedossa P, Valla D, Vidaud M, Marcellin P: Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 2005, 129:2064-2075 (Pubitemid 41772981)
21. Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, Nishioji K, Itoh Y, Okanoue T: Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol 1997, 158:5536-5544 (Pubitemid 127681264)
22. Moore BB, Paine III R, Christensen PJ, Moore TA, Sitterding S, Ngan R, Wilke CA, Kuziel WA, Toews GB: Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol 2001, 167:4368-4377 (Pubitemid 32954313)
23. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C, Wilke CA, Toews GB: CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005, 166:675-684 (Pubitemid 40315625)
24. Kitagawa K, Wada T, Furuichi K, Hashimoto H, Ishiwata Y, Asano M, Takeya M, Kuziel WA, Matsushima K, Mukaida N, Yokoyama H: Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004, 165:237-246 (Pubitemid 38821831)
25. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese Jr RV, Broxmeyer HE, Charo IF: Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997, 100:2552-2561 (Pubitemid 27514895)
26. Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H: Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 2005, 128:138-146 (Pubitemid 40039965)
27. Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, Pinzani M, Laffi G, Montalto P, Gentilini P: Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999, 29:140-148 (Pubitemid 29023996)
28. Hume DA: Macrophages as APC and the dendritic cell myth. J Immunol 2008, 181:5829-5835
29. Osterholzer JJ, Curtis JL, Polak T, Ames T, Chen GH, McDonald R, Huffnagle GB, Toews GB: CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans. J Immunol 2008, 181:610-620
30. Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ, Clark N, Murphy G: Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996, 24:176-184 (Pubitemid 26249431)
31. Preaux AM, D'Ortho MP, Bralet MP, Laperche Y, Mavier P: Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2. Hepatology 2002, 36:615-622
32. Watanabe T, Niioka M, Ishikawa A, Hozawa S, Arai M, Maruyama K, Okada A, Okazaki I: Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. J Hepatol 2001, 35:465-473 (Pubitemid 32964445)
33. Théret N, Musso O, L'Helgoualc'h A, Clement B: Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes. Am J Pathol 1997, 150:51-58
34. Yang X, Lu P, Ishida Y, Kuziel WA, Fujii C, Mukaida N: Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization. Int J Cancer 2006, 118:335-345 (Pubitemid 41779072)
35. Higashiyama R, Inagaki Y, Hong YY, Kushida M, Nakao S, Niioka M, Watanabe T, Okano H, Matsuzaki Y, Shiota G, Okazaki I: Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 2007, 45:213-222 (Pubitemid 46144381)
36. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante Jr AW: CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006, 116:115-124 (Pubitemid 43121796)